Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Return on Equity (2016 - 2025)

vTv Therapeutics' Return on Equity history spans 11 years, with the latest figure at 0.46% for Q4 2025.

  • For Q4 2025, Return on Equity rose 105.0% year-over-year to 0.46%; the TTM value through Dec 2025 reached 0.46%, up 105.0%, while the annual FY2025 figure was 0.81%, 445.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.46% at vTv Therapeutics, up from 0.78% in the prior quarter.
  • Across five years, Return on Equity topped out at 2.94% in Q2 2022 and bottomed at 40.11% in Q1 2024.
  • The 5-year median for Return on Equity is 0.18% (2021), against an average of 1.79%.
  • The largest annual shift saw Return on Equity crashed -4154bps in 2024 before it surged 3794bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 1.13% in 2021, then skyrocketed by 62bps to 1.84% in 2022, then plummeted by -43bps to 1.04% in 2023, then plummeted by -245bps to 1.51% in 2024, then surged by 69bps to 0.46% in 2025.
  • Per Business Quant, the three most recent readings for VTVT's Return on Equity are 0.46% (Q4 2025), 0.78% (Q3 2025), and 4.22% (Q2 2025).